Davinci-franklin Fund I, Led By Chairman Robert Maheu, Announces Initial Seed Round Equity Investment In Medsonix, Inc

DaVinci-Franklin Fund I, LLC. (“DaVinci”) today announced completion of an initial seed round equity investment in Medsonix, Inc., a Nevada Corporation, (“Medsonix”). Proceeds will be used to fund Medsonix’s growth plans and initial marketing programs.

Medsonix, headquartered in Las Vegas, has developed a state of the art technology for non-invasive, therapeutic pain relief method titled the Medsonix Therapy System. This patented technology utilizes a low frequency sound wave generated by an electro-acoustical transducer, also referred as the Cassone transducer, which emits an acoustic energy field on the “whole body” simultaneously. This technology is not to be confused with ultrasound therapies or procedures. This technology introduces a range of patented frequencies that Medsonix controls through an innovative computer and power source system. A therapy session consists of clients simply sitting comfortably in a chair for 25 minutes and no disrobing is required. Robert Maheu, chairman of DaVinci, stated, “There is nothing more important in life than family and health. Medsonix’s system is amazing and provides remarkable results for numerous aches and pains and circulatory problems.” The Medsonix Therapy System, developed by Alphonse Cassone, has received a patent as a medical method from the U.S. Patent Office, is registered as a Class I medical device by the FDA and has completed two successful University studies on its unique treatment for various diseases. A copy of the published study is available at www.medsonix.com. “We are extremely honored to be affiliated with such a high-quality firm,” said Alphonse Cassone, Chief Executive Officer of Medsonix. “Mr. Maheu’s illustrious background combined with DaVinci’s significant experience in working with start-up and early stage growth companies really set them apart from other venture capital firms.” Medsonix has signed Television Host and former news anchor John Daly (www.johndaly.tv) as the company’s spokesperson. “John is the innovative, credible person that can help us promote this cutting edge technology,” says Mr. Cassone. “We are fortunate to have John as he is well-known and respected not only here in the Las Vegas Valley, but also around the country.” “I’m astonished at what Medsonix and the technology has done for people. Even in my personal experience, I had a knot in my back from golf and working out and within a few hours of my Medsonix treatment, it was totally gone,” Daly says. “We can help those with minor aches and pains and circulatory problems with this patented therapeutic procedure.” According to a nationwide government survey, 36 percent of U.S. adults aged 18 years and over use some form of complementary and alternative medicine (CAM). CAM is defined as a group of diverse medical and health care systems, practices, and products that are not presently considered to be part of conventional medicine. Integrative medicine, as defined by NCCAM, combines mainstream medical therapies and CAM therapies for which there is some high-quality scientific evidence of safety and effectiveness.

“Our philosophy is to market the newly patented Medsonix Therapy System in the Complementary/Alternative Therapy industries. The technology will be available through corporately owned Medsonix facilities and Franchise and Stand-alone units. Each product shall be priced to appeal to both the Complementary and Alternative markets as well as the managed-care industry,” stated Bruce Benson, vice president of marketing for Medsonix. “We are extremely excited about our investment in Medsonix due to its extraordinary growth prospects, health benefits of its technology and its commitment to providing non-invasive therapy at reasonable prices to the masses,” said Anthony DeMint, CEO and president of DaVinci. “Our decision to fund Medsonix was relatively easy, their growth potential is immeasurable, their technology has a wide and adaptable market focus and its first facility is already in operation. Further, as a Las Vegas based company we are continuing our commitment towards fostering small business growth and development in the Las Vegas area.” DaVinci was also vital in introducing Medsonix to Stoecklein Law Group, a law firm specializing in federal securities matters, which will assist Medsonix in structuring follow-on rounds of financing with an ultimate goal of going public by the end of 2005. “Our practice is solely focused on assisting small to mid-cap companies through the going public process. With DaVinci’s investment, Medsonix is on a fast track towards completing its goal,” stated Don Stoecklein, principal of the firm. About DaVinci-Franklin Fund I, LLC (DaVinci) DaVinci is a private equity firm providing capital to start-up and development stage companies with strong growth potential, reliable management teams and the desire to be a publicly traded company. DaVinci primarily makes investments in a broad range of growth industries, without a specific emphasis on any one sector. Based in Las Vegas, DaVinci focuses on structuring its portfolio companies for a public exit within 12-18 months and fostering small business growth in the Las Vegas market. About Medsonix Currently, Medsonix has one location in Las Vegas, located at 2626 South Rainbow Blvd. The company is looking to open additional locations across the country using its unique patented therapeutic process to help increase circulation and reduce pain.

Medsonix News and Press Releases

This article has been read 3134 times.

Would you like to own a Medsonix Franchise?

For more information about becoming a Medsonix Franchise owner, including a franchise overview, start-up costs, fees, training and more, please visit our Medsonix Franchise Information page.